Who invested in Xanitos

3 rounds we have observed, with the one investor named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$3.5Mraised across 3 rounds since 2010, from 3 sources

$2.0MSeed$1.5MDebt

Latest round: Debt, $1.5MApr 2014
Biggest round: $2.0MSeed · Sept 2013
Investors: 1

See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

2011201220132014

?Venture$2.0MSeed$1.5MDebt

First round: Venture
Biggest round: $2.0M
Usual gap between rounds: 3 years

The rounds

Apr 2014
Debt$1.5M
No investor was named in the report.
From a historical funding recordSEC filing: $1.5M sold, first sale Mar 2014
Sept 2013
Seed$2.0M
No investor was named in the report.
Reported by sec.govSEC filing: $2.0M sold, first sale Sept 2013
Oct 2010
VentureAmount undisclosed1 new
- InvestMichigan
From a historical funding recordSEC filing: $5.1M sold, first sale Sept 2010

Founders and team

From the SEC filings it signed: 3 on the team.

David A. CrothallChief Operating Officeri
David A. WallsChief Financial Officeri
Graeme A. CrothallExecutive Chairmani

On the board, as filediChris A. GrantElizabeth A. RockettJoe A. ByrumKatherine A. CrothallMichael A. BaileyMichael A. GrossThomas A. MorseWilliam A. Graham

Everyone who backed them

InvestMichiganPrivate equity1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

These 3 firms list Xanitos as a portfolio company on their own websites, but no report of a round names them. They are the firms' own claims, kept apart from the rounds above.